Cadila Healthcare informs about press release

23 Feb 2022 Evaluate

Cadila Healthcare has informed that it enclosed a copy of press release dated February 23, 2022 titled ‘Zydus receives final approval from USFDA for Dapagliflozin Tablets’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

875.05 -6.05 (-0.69%)
20-Jan-2026 12:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.70
Dr. Reddys Lab 1184.30
Cipla 1378.30
Zydus Lifesciences 875.05
Lupin 2163.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×